...
首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Risk Stratification in Follicular Neoplasm-A Cytological Assessment Using the Modified Bethesda Classification
【24h】

Risk Stratification in Follicular Neoplasm-A Cytological Assessment Using the Modified Bethesda Classification

机译:滤泡性肿瘤的风险分层-使用改良贝塞斯达分类的细胞学评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The 2007 Bethesda classification for thyroid cytology defines follicular neoplasm as a category of cases with cellular specimens demonstrating abundant follicular cells arranged in a microfollicular pattern with little or no colloid.The current recommendation for the management of these cases is diagnostic lobectomy. There has been great difficulty and variability in triaging and reporting follicular neoplasm. To increase diagnostic accuracy at the study institution, this category is subclassified further into 3 categories: 1) microfollicular-patterned neoplasm (MN); 2) Hurthle cell neoplasm (HN); and 3) follicular lesion with some features suggestive of but not diagnostic of the follicular variant of papillary thyroid carcinoma (FL). The authors reviewed the cases of follicular neoplasm observed over a period of 5 years to document the follow-up trend using this modified classification, METHODS: A search of the cytology records was performed for the period between January 2008 and December 2012, All thyroid fine-needle aspiration cases were reviewed and those with a diagnosis of follicular neoplasm (including Hurthle cell neoplasm) were identified. Correlating follow-up surgical pathology reports were reviewed, RESULTS: A total of 399 cases of follicular neoplasm with surgical follow-up were identified. Malignancy was identified in 32% of all cases of follicular neoplasm and was found to be disproportionately higher in the FL category (73%). A cytological diagnosis of FL is more likely to be called malignant (73%) than benign neo-plastic (9%) or benign nonneoplastic (18%), A cytological diagnosis of MN or HN is more likely to be benign neoplastic (46% and 46%, respectively) than malignant (29% and 26%, respectively) or benign nonneoplastic (25% and 28%, respectively). Of the cytological features examined, 2 (nuclear enlargement and nuclear grooves) were significantly associated with the follicular variant of papillary thyroid carcinoma. CONCLUSIONS: The results of the current study clearly indicate that follicular lesions with even subtle nuclear atypia have a high positive predictive value for malignancy and therefore should be distinguished from other follicular lesions because these cases require more aggressive surgical management. The current study also raises an important issue concerning the current thyroid classification based on the 2007 Bethesda classification for thyroid cytology. Future thyroid fine-needle aspiration classification schemes should consider subclassifying follicular neoplasms for the purpose of risk stratification.
机译:摘要背景:2007年Bethesda甲状腺细胞学分类法将滤泡性肿瘤定义为一类病例,其细胞标本显示大量滤泡细胞排列成微泡模式,胶体很少或没有胶体,目前建议对这些病例进行诊断性肺叶切除术。在分类和报告滤泡性肿瘤方面存在很大的困难和可变性。为了提高研究机构的诊断准确性,此类别可进一步细分为3类:1)微囊样肿瘤(MN); 2)hurthle细胞瘤(HN); 3)具有某些特征的卵泡病变,提示但不能诊断乳头状甲状腺癌(FL)的卵泡变异。作者回顾了5年内观察到的滤泡性肿瘤病例,以使用这种改进的分类记录随访趋势。方法:对2008年1月至2012年12月的细胞学记录进行搜索,所有甲状腺功能正常回顾了针吸病例,并鉴定出诊断为滤泡性肿瘤的患者(包括Hurthle细胞瘤)。回顾了相关的手术病理报告,结果:共鉴定出399例滤泡性肿瘤并进行了手术随访。在所有滤泡性肿瘤病例中,有32%发现了恶性肿瘤,而在FL类中则发现恶性肿瘤的比例更高(73%)。与良性肿瘤(9%)或良性非肿瘤性(18%)相比,FL的细胞学诊断更有可能被称为恶性(73%),MN或HN的细胞学诊断更可能是良性肿瘤(46%)。 (分别为29%和26%)或良性非肿瘤性(分别为25%和28%)和46%)。在所检查的细胞学特征中,有2个(核增大和核槽)与甲状腺乳头状癌的滤泡变体显着相关。结论:目前的研究结果清楚地表明,即使是细微的核型异型的滤泡性病变对恶性肿瘤也具有较高的阳性预测价值,因此应与其他滤泡性病变区分开来,因为这些病例需要更积极的手术治疗。当前的研究还提出了一个重要问题,涉及基于2007年Bethesda甲状腺细胞学分类的当前甲状腺分类。未来的甲状腺细针穿刺分类方案应考虑将滤泡性肿瘤亚分类以进行危险分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号